Scarica l'app Stockscreener
1.24
0.00%
0.00
Precedente Chiudi:
$1.24
Aprire:
$1.23
Volume 24 ore:
171.97K
Relative Volume:
0.48
Capitalizzazione di mercato:
$66.13M
Reddito:
-
Utile/perdita netta:
$-78.34M
Rapporto P/E:
-0.8368
EPS:
-1.4819
Flusso di cassa netto:
$-75.02M
1 W Prestazione:
+1.64%
1M Prestazione:
+16.98%
6M Prestazione:
+5.08%
1 anno Prestazione:
-2.36%
Intervallo 1D:
$1.20
$1.265
Intervallo di 1 settimana:
$1.20
$1.28
Portata 52W:
$1.02
$1.88
Pmv Pharmaceuticals Inc Stock (PMVP) Company Profile
Nome
Pmv Pharmaceuticals Inc
Settore
Industria
Telefono
(609) 642-6670
Indirizzo
400 ALEXANDER PARK DRIVE, PRINCETON
Compare PMVP vs VRTX, REGN, ARGX, ALNY, RVMD
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
PMVP
Pmv Pharmaceuticals Inc
|
1.24 | 66.13M | 0 | -78.34M | -75.02M | -1.4819 |
VRTX
Vertex Pharmaceuticals Inc
|
485.39 | 123.19B | 12.34B | 4.34B | 3.71B | 16.87 |
REGN
Regeneron Pharmaceuticals Inc
|
664.52 | 69.67B | 14.92B | 4.42B | 3.79B | 41.04 |
ARGX
Argen X Se Adr
|
877.62 | 54.58B | 4.16B | 1.29B | 734.26M | 19.58 |
ALNY
Alnylam Pharmaceuticals Inc
|
298.76 | 39.89B | 4.29B | 577.22M | 641.34M | 4.2086 |
RVMD
Revolution Medicines Inc
|
186.88 | 39.73B | 742.00K | -1.37B | -1.07B | -7.0731 |
Pmv Pharmaceuticals Inc Stock (PMVP) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2024-11-08 | Aggiornamento | Oppenheimer | Perform → Outperform |
| 2024-05-13 | Iniziato | Craig Hallum | Buy |
| 2024-04-12 | Iniziato | Jefferies | Buy |
| 2023-12-27 | Iniziato | Ladenburg Thalmann | Buy |
| 2022-03-02 | Aggiornamento | Oppenheimer | Perform → Outperform |
| 2021-09-22 | Aggiornamento | Goldman | Neutral → Buy |
| 2021-08-19 | Iniziato | Oppenheimer | Perform |
| 2021-08-02 | Iniziato | Guggenheim | Buy |
| 2021-07-29 | Iniziato | H.C. Wainwright | Buy |
| 2020-10-20 | Iniziato | BofA Securities | Buy |
| 2020-10-20 | Iniziato | Cowen | Outperform |
| 2020-10-20 | Iniziato | Evercore ISI | Outperform |
| 2020-10-20 | Iniziato | Goldman | Neutral |
Mostra tutto
Pmv Pharmaceuticals Inc Borsa (PMVP) Ultime notizie
ArrowMark Colorado Holdings (PMVP) holds 3.67% stake in PMV Pharmaceuticals - Stock Titan
PMV Pharmaceuticals outlines its cancer drug pipeline as shares trade quietly - ad-hoc-news.de
PMV Pharmaceuticals (PMVP) upgraded to buy: Here's why - MSN
PMV Pharmaceuticals holds the focus as investors await the next catalyst. - ad-hoc-news.de
July 2026's Spotlight On Promising Penny Stocks - Sahm
Enterprise value to EBITDA forward of PMV Pharmaceuticals, Inc. – NASDAQ:PMVP - TradingView
Price to earnings forward of PMV Pharmaceuticals, Inc. – NASDAQ:PMVP - TradingView
Enterprise value to revenue forward of PMV Pharmaceuticals, Inc. – NASDAQ:PMVP - TradingView
Price to book forward of PMV Pharmaceuticals, Inc. – NASDAQ:PMVP - TradingView
Enterprise value to EBIT forward of PMV Pharmaceuticals, Inc. – NASDAQ:PMVP - TradingView
PMV Pharmaceuticals, Inc. Actuals & Estimates (NASDAQ:PMVP) - TradingView
PMVP Forecast — Price Target — Prediction for 2027 - TradingView
PMV Pharmaceuticals Inc (PMVP) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey
PMV Pharmaceuticals (PMVP) Upgraded to Buy: Here's Why - Yahoo Finance
PMV Pharmaceuticals Inc (PMVP) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
PMV Pharmaceuticals Inc (PMVP) Valuation: PE, PB & Fair Value Analysis - TradingKey
PMV Pharmaceuticals Inc (PMVP) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey
PMV Pharmaceuticals Inc (PMVP) Institutional Confidence - TradingKey
PMV Pharmaceuticals Inc (PMVP) Financial Health: Profitability & Balance Sheet Analysis - TradingKey
PMV Pharmaceuticals Inc (PMVP) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
PMV Pharmaceuticals Inc (PMVP) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey
PMV Pharmaceuticals Inc (PMVP) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey
PMVP Q1 2026 Earnings: Narrower-Than-Expected Loss Mitigates Stock DeclineEarnings Risk Report - newsline.com
PMVP SEC FilingsPmv Pharmaceuticals, Inc. 10-K, 10-Q, 8-K Forms - Stock Titan
PMV Pharmaceuticals Stock (US7301281085): Quiet session puts fundamentals and balance sheet in focus - AD HOC NEWS
PMV Pharmaceuticals (PMVP) loses 26% in 4 weeks, here's why a trend reversal may be around the corner - MSN
PMV Pharmaceuticals (PMVP) Q1 2026 Earnings: EPS Beat Driven by Tight Cost Control, Stock Slips on Lack of RevenueEarnings Quality Score - newsline.com
PMV Pharmaceuticals (PMVP) Loses 26% in 4 Weeks, Here's Why a Trend Reversal May be Around the Corner - Yahoo Finance
PMV Pharmaceuticals Slips Slightly as Shares Approach Critical SupportCounter Trend Trade - newsline.com
PMV Pharmaceuticals (PMVP) Dips 3.5% as Stock Tests Key Support at $1.0Golden Cross - dars.gov.et
PMV Pharmaceuticals (PMVP) grants director 42,000 options at $1.19 - Stock Titan
PMV Pharmaceuticals (PMVP) director receives 42,000 stock options at $1.1900 - Stock Titan
PMV Pharmaceuticals (PMVP) director gifts 84K stock options to trust - Stock Titan
PMV Pharmaceuticals (PMVP) director awarded 42,000 stock options at $1.19 - Stock Titan
Director at PMV Pharmaceuticals (PMVP) granted 42,000 options at $1.19 - Stock Titan
PMV Pharmaceuticals, Inc. Files Form 8-K with SEC Detailing Company Information and Annual Meeting Results - Minichart
PMV Pharmaceuticals Shareholders Back Directors and Governance Matters - TipRanks
Shareholders back PMV Pharmaceuticals (NASDAQ: PMVP) board, pay plans - Stock Titan
PMVP: Directors elected, compensation and auditor ratified, with no stockholder questions raised - TradingView
PMV Pharmaceuticals Inc Annual Shareholders Meeting Transcript - GuruFocus
PMV Pharmaceuticals Q1 2026 Earnings: EPS Beat Narrows Losses Amid Pre-Revenue Pipeline ProgressEarnings Season Outlook - newsline.com
PMVP Q1 2026 Earnings: Narrower-Than-Expected Loss Drives Positive SurpriseNext Quarter Guidance - newsline.com
PMV Pharmaceuticals Advances Cancer Study Amid Adjusted Financial Targets - asatunews.co.id
PMV Pharmaceuticals Advances Cancer Drug Development Amid Financial Adjustments - sekbernews.id
Why PMV Pharmaceuticals, Inc. (PMVP) Faces Funding Concerns Despite Positive Trial Activity - Insider Monkey
5 Popular Penny Stocks on Robinhood to Watch in 2026 - Insider Monkey
PMVPPMV Pharmaceuticals Inc Latest SEC Filings - Finviz
PMVP Q1 2026 Earnings: Narrower-Than-Expected Loss as Clinical Pipeline ProgressesEarnings Seasonality - dars.gov.et
PMVP Q1 2026 Earnings: Narrower Loss Slightly Beats Estimates as Development AdvancesRevenue Miss Report - The Legal Advocate
PMV Pharmaceuticals’ Phase 2 Clinical Trial Progresses; Reports $5 Million in First-Quarter Revenue - geneonline.com
PMV Pharmaceuticals (PMVP) Slips to $1.26 as Cautious Trading Puts Support to the TestCalendar Spread Trade - Newser
Pmv Pharmaceuticals Inc Azioni (PMVP) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
Pmv Pharmaceuticals Inc Azioni (PMVP) insider trading
| Commercio interno | Relazione | Data | Transazione | Costo | #Azioni | Valore ($) | #Azioni Totale |
|---|---|---|---|---|---|---|---|
| ORBIMED ADVISORS LLC | 10% Owner |
Oct 23 '25 |
Sale |
1.52 |
1,000,000 |
1,520,000 |
4,975,291 |
2.64%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):